20 Recruiting Studies Using Vinorelbine
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Vinorelbine
Evolutionary Therapy for Rhabdomyosarcoma
📍 University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama
Rhabdomyosarcoma
View Study & Checklist ➔Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Resectable Lung Non-Small Cell Carcinoma
View Study & Checklist ➔A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Alveolar Rhabdomyosarcoma
View Study & Checklist ➔The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
Breast Cancer
View Study & Checklist ➔Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Alveolar Rhabdomyosarcoma
View Study & Checklist ➔A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)
📍 Research Site — Duarte, California
Breast Cancer
View Study & Checklist ➔A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
📍 Rush University Medical Center — Chicago, Illinois
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma
📍 Rebecca Phelan — Los Angeles, California
Rhabdomyosarcoma
View Study & Checklist ➔A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features
📍 Research Site — Tucson, Arizona
Non-small Cell Lung Cancer
View Study & Checklist ➔Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
📍 Highlands Oncology Group — Fayetteville, Arkansas
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
📍 USA Mitchell Cancer Institute-Clinical Trials ( Site 4126) — Mobile, Alabama
Cervical Cancer
View Study & Checklist ➔LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients
📍 University of Illinois Cancer Center — Chicago, Illinois
NSCLC
View Study & Checklist ➔A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
📍 Children's Hospital of Alabama — Birmingham, Alabama
Rhabdomyosarcoma
View Study & Checklist ➔A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
📍 University of Miami — Miami, Florida
Hodgkin Lymphoma
View Study & Checklist ➔A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
📍 Childrens Hospital of Alabama — Birmingham, Alabama
Neoplasms
View Study & Checklist ➔Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
📍 City of Hope Cancer Center (Data Collection Only) — Duarte, California
Hodgkin Lymphoma
View Study & Checklist ➔ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
📍 University of California Davis — Davis, California
Hodgkin Lymphoma, Adult
View Study & Checklist ➔Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
📍 Stanford University — Palo Alto, California
Rhabdomyosarcoma
View Study & Checklist ➔A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
📍 Mayo Clinic Scottsdale - PPDS — Phoenix, Arizona
Metastatic HER2-positive Breast Cancer
View Study & Checklist ➔ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
📍 The University of Arizona Cancer Center - North Campus — Tucson, Arizona
Breast Cancer, Metastatic
View Study & Checklist ➔